Functional expression of a pseudohypoaldosteronism type I mutated epithelial Na+ channel lacking the pore-forming region of its alpha subunit.
The autosomal recessive form of type I pseudohypoaldosteronism (PHA-I) is an inherited salt-losing syndrome resulting from diminution-of-function mutations in the 3 subunits of the epithelial Na+ channel (ENaC). A PHA-I stop mutation (alpha(R508stop)) of the ENaC alpha subunit is predicted to lack the second transmembrane domain and the intracellular COOH-terminus, regions of the protein involved in pore function. Nonetheless, we observed a measurable Na+ current in Xenopus laevis oocytes that coexpress the beta and gamma subunits with the truncated alpha subunit. The mutant alpha was coassembled with beta and gamma subunits and was present at the cell surface at a lower density, consistent with the lower Na+ current seen in oocytes with the truncated alpha subunit. The single-channel Na+ conductance for the mutant channel was only slightly decreased, and the appearance of the macroscopic currents was delayed by 48 hours with respect to wild-type. Our data suggest novel roles for the alpha subunit in the assembly and targeting of an active channel to the cell surface, and suggest that channel pores consisting of only the beta and gamma subunits can provide significant residual activity. This activity may be sufficient to explain the absence of a severe pulmonary phenotype in patients with PHA-I.
Bonny
O
O
Institut de Pharmacologie et de Toxicologie, Université de Lausanne, CH-1005 Lausanne, Switzerland.
Chraibi
A
A
Loffing
J
J
Jaeger
N F
NF
Gründer
S
S
Horisberger
J D
JD
Rossier
B C
BC
D000584:Amiloride / Q000494:pharmacology; D000818:Animals; D018388:Codon, Terminator; D053503:Epithelial Sodium Channels; D005260:Female; D005808:Genes, Recessive; D006801:Humans; D006994:Hypoaldosteronism / Q000235:genetics*; D046911:Macromolecular Substances; D016297:Mutagenesis, Site-Directed; D009865:Oocytes / Q000502:physiology; D051381:Rats; D011994:Recombinant Proteins / Q000187:drug effects / Q000378:metabolism; D017384:Sequence Deletion; D015222:Sodium Channels / Q000187:drug effects / Q000235:genetics* / Q000502:physiology; D014982:Xenopus laevis
D018388:Codon, Terminator; D053503:Epithelial Sodium Channels; D046911:Macromolecular Substances; D011994:Recombinant Proteins; D015222:Sodium Channels; D000584:Amiloride